new Alzheimer's drug, Exelon (rivastigmine, Novartis)

June 2000

You're going to start hearing about the new Alzheimer's drug, Exelon (rivastigmine, Novartis).

Exelon is a cholinesterase inhibitor...similar to Aricept.

These drugs offer modest benefits for patients with mild to moderate Alzheimer's. They may slightly improve cognitive abilities and delay the need for nursing home placement.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Handheld computers
Vitamins & Minerals Institute of Medicine's new recommendations for vitamin E
Men's Health new testosterone gel
St. John's wort might reduce the effectiveness of oral contraceptives
Diabetes more patients using Humalog right AFTER meals
Diabetes Lantus, a new long-acting insulin
Women's Health treatments for female sexual dysfunction
Migraine Lots of attention is now being focused on migraines
NSAIDs new NSAID for osteoarthritis called Mobic (meloxicam)
NSAIDs Vioxx might increase the risk of heart attack
Alzheimer's Disease new Alzheimer's drug, Exelon (rivastigmine, Novartis)
Obesity & Weight Loss many patients are trying to lose weight

new Alzheimer's drug, Exelon (rivastigmine, Novartis)

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents